About Gallipro® Fit:
Gallipro® Fit contains a highly-selected strain of Bacillus licheniformis, that, when drunk daily, has been proven to reduce the risk of necrotic enteritis (NE) due to Clostridium perfringens. Numerous trials showed that Gallipro® Fit improves flock performance with demonstrable economic benefits.
Gallipro® Fit improves performance and reduces the risk of NE in the presence of C. perfringens:
In a broiler study, under NE challenge, daily drinking of Gallipro® Fit resulted in improved performance, with significantly reduced Necrotic Enteritis lesion scores at 42 days of age. The highly-selected strain of B. licheniformis competitively inhibits the proliferation of C. perfringens and improves the stability and function of the GI tract. (Virginia Diversified Research Corporation, USA, 2016).
In an in-house research trial, GalliPro© Fit demonstrated the ability to inhibit the growth of Clostridium perfringens (Type A and Type C; Chr Hansen AH innovation, 2014; IZ = Inhibition zone).